Contemporary management of atherosclerotic renovascular disease: Before and after ASTRAL

James Ritchie, Constantina Chrysochou, Philip A. Kalra

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Atheromatous renovascular disease is an increasingly common diagnosis in our ageing population. Although there is a wide spread of experience in its treatment, the evidence base is heterogeneous and inconclusive. The Angioplasty and Stenting for Renal Artery Lesions trial has provided some, but not all, answers regarding the place of renal revascularization therapy and has also raised more questions and generated further debate. We present a brief review of the significance of atheromatous renovascular disease, discussion of historical treatments, a short analysis of Angioplasty and Stenting for Renal Artery Lesions, and an exploration of where future research lies. This paper provides a literature review of the prevalence and diagnostic criteria of atherosclerotic renovascular disease (ARVD), imaging for ARVD and prognostic implications of ARVD (including renal and cardiovascular implications). A discussion of the literature on therapeutic aspects follows, essentially before and after the large Angioplasty and Stenting for Renal Artery Lesions trial. Other therapies are discussed such as statin therapy and antiplatelet agents. Limitations and questions arising from Angioplasty and Stenting for Renal Artery Lesions are raised and future directions of the management of AVRD are considered. © 2011 Asian Pacific Society of Nephrology.
    Original languageEnglish
    Pages (from-to)457-467
    Number of pages10
    JournalNephrology
    Volume16
    Issue number5
    Publication statusPublished - Jul 2011

    Keywords

    • angioplasty
    • ASTRAL
    • atherosclerotic renovascular disease (ARVD)
    • biomarkers
    • hypertension

    Fingerprint

    Dive into the research topics of 'Contemporary management of atherosclerotic renovascular disease: Before and after ASTRAL'. Together they form a unique fingerprint.

    Cite this